Interius BioTherapeutics is a startup based in the United States, 1 tracked investor.
Interius BioTherapeutics is a startup founded in 2018 based in the United States. Brouky records 1 investor associated with the company.
Interius BioTherapeutics is a clinical-stage biotechnology company that develops targeted, programmable lentiviral vectors (LENTIVECTOR platform) to deliver genetic medicines in vivo. Its platform is being applied to enable off-the-shelf genetic therapies, including approaches to simplify CAR T–style treatments for cancer and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.